baber/WOPTO huggingface dataset:
Patent AU-576851-B2 (AU)
Title: Well cementing composition
Inventor: GEORGE CHARLES RAY
IPC: C04B24/16
Filed: 1985-05-06
Granted: 1988-09-08
Abstract: Cement compositions for use in oil, gas and water well cementing operations comprise cement, water and a polymeric additive prepared by caustic-catalyzed condensation of formaldehyde with acetone, or a substance derived from acetone, wherein said polymer includes sodium sulfonate groups in an amount sufficient to render such polymer water soluble. A second fluid loss additive such as hydroxyethyl cellulose, carboxymethylhydroxyethyl cellulose, copolymers of N, N-dimethylacrylamide and 2-acrylamido-2-methyl-propane sulfonic acid or copolymers of acrylamide and 2-acrylamido, 2-methyl-propane sulfonic acid may optinally be included.
Patent AU-667728-B2 (AU)
Title: Method for improving measurement precision in evanescent wave optical biosensor assays
Inventor: ATTRIDGE JOHN WORTHINGTON
IPC: G01N21/76
Filed: 1993-06-09
Granted: 1996-04-04
Abstract: PCT No. PCT/GB93/01217 Sec. 371 Date Dec. 12, 1994 Sec. 102(e) Date Dec. 12, 1994 PCT Filed Jun. 9, 1993 PCT Pub. No. WO93/25908 PCT Pub. Date Dec. 23, 1993A method for improving measurement precision in an optical biosensor assay for a ligand in a sample is described. The method involves referencing the assay with an artificially raised background level by the labelling of the optical waveguide with an appropriate reference reagent. Devices for use in such a method are also described.
Patent AU-618639-B2 (AU)
Title: Purification of phosphorus compounds
Inventor: DAVIES PAUL MICHAEL
IPC: C07F9/38
Filed: 1989-11-02
Granted: 1992-01-02
Abstract: The content of hydrogen chloride and phosphorous acid of crude amino organic phosphonic acids, especially diethylenetriaminepentakis (methylene phosphonic acid) is reduced by solvent extraction into an alcoholic phase leaving purified phosphonic acid behind.
Patent AU-599570-B2 (AU)
Title: Immunogenic conjugates of E. coli LT-B enterotoxin subunit and capsular polymers
Inventor: ANDERSON PORTER W
IPC: A61K39/095
Filed: 1985-07-04
Granted: 1990-07-26
Abstract: The invention relates to immunogenic conjugates of E. coli LT-B enterotoxin subunit and capsular polymers, methods for the preparation of the conjugates, a vaccine containing the conjugates which elicits effective levels of anti-capsular polymer antibodies in humans. Also disclosed are methods for including active immunization against systemic infection in young mammals caused by bacterial pathogens comprising the administration of an immunogenic amount of the above-described conjugate.
Patent AU-740888-B2 (AU)
Title: Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP
Inventor: RUPAR MARK J
IPC: A01N63/50
Filed: 1997-09-25
Granted: 2001-11-15
Abstract: Disclosed is a novel ´-endotoxin, designated CryET29, that exhibits insecticidal activity against siphonopteran insects, including larvae of the cat flea ( Cteno-cephalides felis),  as well as against coleopteran insects, including the southern corn rootworm  (Diabrotica undecimpunctata),  western corn rootworm ( D. virgif-era ) ,  Colorado potato beetle ( Leptinotarsa decemlineata ) ,  Japanese beetle ( Popil-lia japonica ) ,  and red flour beetle ( Tribolium castaneum ) .  Also disclosed are nucleic acid segments encoding CryET29, recombinant vectors, host cells, and transgenic plants comprising a  cryET29  DNA segment. Methods for making and using the disclosed protein and nucleic acid segments are disclosed as well as assays and diagnostic kits for detecting  cryET29  and CryET29 sequences  in vivo  and  in vitro.
Patent AU-717040-B2 (AU)
Title: Cooling pouch
Inventor: WOLSEY HENRY GARNET
IPC: A61J1/14
Filed: 1997-10-23
Granted: 2000-03-16
Abstract: A portable flexible cooling pouch for cooling and storing vials containing medication. The pouch comprises opposed web members made of a water permeable material which are connected at the edges thereof. At least one of the web members comprises a plurality of compartments which contain a water-absorbent granular material.
Patent AU-620212-B2 (AU)
Title: Method for manufacturing an element with a synthetic foam layer and element obtained by that method
Inventor: RUYVER STEFAAN DE
IPC: B32B38/08
Filed: 1990-02-26
Granted: 1992-02-13
Abstract: A method for manufacturing an element with a synthetic foam layer, which is covered on at least one side with a finishing layer, whereby there is started from a layer (1) of substantially flexible mainly open cell synthetic foam which is at least partially impregnated with a liquid comprising NCO-groups, wherein, after having at least partially impregnated said synthetic foam layer (1) with said liquid comprising NCO-groups, said impregnated synthetic foam layer is brought together with a finishing layer (4, 4 min ), a whole (8) constituted of those layers (1, 4, 4 min ) being compressed and, in said compressed state, steam is brought at least in said synthetic foam layer (1) at such a temperature and during a sufficient time that said NCO-groups of said liquid should react with said steam.
Patent AU-624920-B2 (AU)
Title: Lubricant and use thereof
Inventor: SCHMITZ KARL-HEINZ
IPC: C02F9/00
Filed: 1990-02-14
Granted: 1992-06-25
Abstract: Disclosed is a lubricant based on amines and, where appropriate, the usual thinners or auxiliaires/additives, the lubricant containing at least one secondary and/or tertiary amine and/or salts of such amines and the proportion of amines in the whole composition being 1 to 100 % by wt. Lubricants of this kind are preferably used as chain lubricants in the food industry, particularly for automatic chain and belt lubrication installations.
Patent AU-581481-B2 (AU)
Title: Gain controlled electronic ballast system
Inventor: HANLET JACQUES M
IPC: H05B41/282
Filed: 1985-12-17
Granted: 1989-02-23
Abstract: A frequency stabilized automatic gain controlled ballast system (10) which is coupled to a power source (12) in order to operate at least one of a pair of gas discharge tubes (40 and 40'). Each of the gas discharge tubes (40, 40') include respective filaments (42, 44 and 42', 44'). A frequency control circuit (11) is coupled to the power source (12) and includes a frequency control transformer (43) and a frequency control capacitor (50) for establishing a constant oscillation signal at a predetermined frequency. A switching network (13) is connected to the frequency control circuit (11) for establishing a pulsating current responsive to the constant oscillation signal of predetermined frequency. Induction circuitry (15) is coupled to the switching network (13) and the frequency control circuit (11) and includes an inverter transformer (78) as well as coupling capacitors (86 and 88) for generating a voltage across the gas discharge tubes (40 and 40'). Automatic gain control circuitry (17) is included in inverter transformer (78) and is made up of a pair of secondary windings (80 and 81) wound in a manner to provide a negative feedback voltage to each of the transistors (70 and 70') of switching network (13). The inverter transformer (78) has a pair of primary windings (82 and 84) which operate alternately and are coupled to the primary winding (45) of frequency control transformer (43) to provide a repetitive cycle. First and second coupling capacitors (86 and 88) are coupled to primary windings (82 and 84) of inverter transformer (78) and filaments (42 and 42') of gas discharge tubes (40 and 40') for discharging the induced voltage across the tubes (40 and 40').
Patent AU-627582-B2 (AU)
Title: Liquid herbicides containing surfactants
Inventor: ALBRECHT KONRAD
IPC: A01N43/76
Filed: 1990-05-31
Granted: 1992-08-27
Abstract: The present invention relates to liquid herbicidal agents in the form of emulsifiable concentrates (EC) or concentrated emulsion (EW), characterised in that they contain, besides 1 - 40% by weight of the active substance diclofop-methyl (I), fenoxaprop-ethyl (II) or its optically active isomer (D+) fenoxaprop-P-ethyl (III), 0.5 - 30% by weight of (C10-C18) fatty alcohol polyglycol ethers or (C8- C9)alkylphenyl polyglycol ethers which are 6 to 10 times ethoxylated as surfactants, and, in the case of EC formulations, 0.5 - 7% by weight of calcium (C18-C14)alkylbenzenesulphonate and, in the case of EW formulations, 0.5 - 7% by weight of an ethylene oxide/propylene oxide/ethylene oxide block copolymer which is phosphorylated in the alpha- and omega-position or a salt thereof as dispersant, besides the customary formulation components. Compared with the known active substance formulations, these agents have markedly increased activities and improved miscibility properties with water and with commercially available preparations containing other active substances.
Patent AU-639471-B2 (AU)
Title: Amines catalysis using metallic polyphosphate condensation catalysts having a condensed structure
IPC: C07B61/00
Filed: 1990-08-07
Granted: 1993-07-29
Abstract: This invention relates to a process for making amines by condensing an amino compound in the presence of a metallic polyphosphate condensation catalyst having a condensed structrue. This invention also relates to an alkyleneamines producers composition rich in triethylenetetramine (TETA), tetraethylenepentamine (TEPA) and pentaethylenehexamine (PEHA).
Patent AU-717890-B2 (AU)
Title: Immunological combination compositions and methods
Inventor: BECKER ROBERT S
IPC: A61K31/00
Filed: 1996-06-05
Granted: 2000-04-06
Abstract: Immununological compositions and methods for making and using them. The compositions contain at least one antigen and at least one lipoprotein and optionally an adjuvant. The lipoprotein can itself be antigenic or immunogenic. The antigen can be influenza HA and the lipoprotein a recombinantly expressed product having an OspA leader for lipidation and PspA for the protein portion. The antigen can be OspC and the lipoprotein OspA. The components of the composition are co-administered. A potentiated immunological response is obtained by the compositions and methods.
Patent AU-700654-B2 (AU)
Title: Controlled release formulations for poorly soluble drugs
Inventor: CLANCY MAURICE JOSEPH ANTHONY
IPC: A61K47/34
Filed: 1996-07-01
Granted: 1999-01-14
Abstract: A controlled release formulation for oral administration comprises a solid dispersion of a poorly soluble active ingredient in a hydrophilic poloxamer, the solid dispersion being a component of a core and the core as such or following coating of the core with a polymeric coating being effective to achieve therapeutic levels of the active ingredient over extended periods of time (24 hours or longer) following oral administration. The formulation can be in a multi-particulate form such as pellets or mini-tablets or in the form of tablets. Examples of active ingredients whose solubility and therapeutic effectiveness can be improved with the formulation are cisapride, cyclosporin, diclofenac, felodipine, ibuprofen, indomethacin, nicardipine, nifedipine, terfenadine and theophylline.
Patent AU-744126-B2 (AU)
Title: Arrangement for coupling of a driver to a coupling site of the ossicular chain
Inventor: MULLER GERD M
IPC: A61F2/18
Filed: 2000-09-29
Granted: 2002-02-14
Abstract: The arrangement has a first half (36) of the coupling (34) with an outer contour with at least approximately the shape of a spherical cup that can be accommodated in the inner contour of a second coupling half (38) that is at least partly complementary, whereby the coupling is reversibly pivotable and/or rotatable against frictional forces, but is essentially rigid under dynamic forces occurring in the implanted state.
Patent AU-771706-B2 (AU)
Title: Methods and apparatus for preparation of lipid vesicles
Inventor: KNOPOV VICTOR
IPC: A61K45/00
Filed: 2000-07-14
Granted: 2004-04-01
Abstract: Fully lipid-encapsulated therapeutic agent particles of a charged therapeutic agent are prepared by combining a lipid composition containing preformed lipid vesicles, a charged therapeutic agent, and a destabilizing agent to form a mixture of preformed vesicles and therapeutic agent in a destabilizing solvent. The destabilizing solvent is effective to destabilize the membrane of the preformed lipid vesicles without disrupting the vesicles. The resulting mixture is incubated for a period of time sufficient to allow the encapsulation of the therapeutic agent within the preformed lipid vesicles. The destabilizing agent is then removed to yield fully lipid-encapsulated therapeutic agent particles. The preformed lipid vesicles comprise a charged lipid which has a charge which is opposite to the charge of the charged therapeutic agent and a modified lipid having a steric barrier moiety for control of aggregation.
Patent AU-760812-B2 (AU)
Title: Cloning and recombinant production of (polistinae) venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
Inventor: KING TE PIAO
IPC: C07K19/00
Filed: 1999-10-01
Granted: 2003-05-22
Abstract: A unique clone of a Polistinae venom enzyme, recombinantly produced Polistinae venom enzymes, and methods of using the recombinant enzymes are provided. In a specific example, both phospholipase and hyaluronidase cDNA from Polistes annulares contain apparent "intronic" sequences. In still a further enbodiment, genetic engineering permits the construction of the "intronic" sequences to yield a useful coding sequence for expression of mature Polistinae venom enzyme proteins.
Patent AU-639039-B2 (AU)
Title: Belt tensioner and method of making the same
IPC: F16H7/12
Filed: 1990-10-04
Granted: 1993-07-15
Abstract: A belt tensioner and method of making the same are provided, the tensioner comprising a support for being fixed relative to a belt, a belt engaging arm carried by the support and being movable relative thereto, a spring operatively associated with the support and the belt engaging arm for urging the belt engaging arm relative to the support and against the belt with a force to tension the belt, the support comprising a shaft having a longitudinal axis, the belt engaging arm being rotatably mounted on the shaft, the arm having a bearing surface angled relative to the axis and the support having a bearing surface angled relative to the axis and facing the bearing surface of the arm, and a bushing disposed between the bearing surfaces and in engagement therewith to facilitate movement therebetween and to tend to prevent cocking of the arm on the shaft when the belt engaging arm is tensioning the belt.
Patent AU-773842-B2 (AU)
Title: Conjugate for mediating cell, compartment or membrane-specific transport of active substances
Inventor: BRAUN KLAUS
IPC: A61K47/48
Filed: 2000-07-14
Granted: 2004-06-10
Abstract: The present invention relates to conjugates for mediating a cell-specific, compartment-specific or membrane-specific to methods of active substances. The invention also relates to methods of preparing these conjugates as well as their use. The conjugates comprise:a transport mediator for the cell membrane,a cell-specific, compartment-specific or membrane-specific address protein or peptide, andan active substance to be transported.
Patent AU-661433-B2 (AU)
Title: Pet access door frame modular unit
Inventor: DAVLANTES GEORGE N
IPC: A01K1/035
Filed: 1994-07-20
Granted: 1995-07-20
Abstract: A modular pet access door unit for insertion into a hole cut into a door or wall has exterior frames and spacer frames, fastened together by fasteners extending horizontally through brackets in the spacer frames. The spacer frames have tongue and groove surfaces for nesting with each other. Both exterior frames may carry a pet access door. A security cover mounts on posts with annular grooves, and may be moved horizontally into position to cover the pet opening, where sliders in the security cover with keyhold-shaped holes engage the post annular grooves. The pet door is captured in the frame between the frame and a door or flap holder that is secured to the frame by removably fasteners. An automatically adjustable sill is movable by magnetic attraction to the flap bottom, where its position is secured by fasteners.
Patent AU-593617-B2 (AU)
Title: Zero insertion force socket for photoactivation patient treatment system
Inventor: TROUTNER VERNON H
IPC: A61M1/26
Filed: 1987-02-26
Granted: 1990-02-15
Abstract: Automatic operating zero insertion force socket for use in a photoactivatable reagent treatment system wherein photoactivatable agents, in contact with patient blood cells, are irradiated extracorporeally and then returned to the patient.
Patent AU-646009-B2 (AU)
Title: Humanised antibodies
Inventor: ADAIR JOHN ROBERT
IPC: A61K39/395
Filed: 1990-12-21
Granted: 1994-02-03
Abstract: CDR grafted antibody is claimed having one chain derived from a first (acceptor) antibody and (pref. 2) CDR(s) derived from a second (donor) antibody. Residue(s) pref. residue 35 in the CDR grafted chain has been altered so it corresp. to the equiv. residue in the antibody. The CDR chains are pref. derived from a human lgG chain. The heavy chain may be derived from the human NEW M or EU or pref. KOL chain. The light chain is pref. derived from the human REl light chain. The CDR grafted antibody has an affinity for the CD4 antigen of 10power5 - 10power12 M-1 pref. 10power8. Affinity is similar to that of OKT4A. CDR(s) may be derived from a mammalian (murine) antibody. Prodn. of the antibody is claimed by recombinant DNA technology.
Patent AU-641212-B2 (AU)
Title: Nonionic iodinated compounds, method for preparing them, and contrast products containing same
Inventor: SCHAEFER MICHEL
IPC: A61K49/04
Filed: 1990-12-28
Granted: 1993-09-16
Abstract: Compounds having general formula (I), wherein R is selected among 2,3-dihydroxypropyl and 1,3-dihydroxy-2-propyl groups. These compounds can be used as contrasting products for X-ray image formation.
Patent AU-718439-B2 (AU)
Title: Human growth hormone variants
Inventor: CUNNINGHAM BRIAN C
IPC: A61K47/48
Filed: 1996-09-20
Granted: 2000-04-13
Abstract: Human growth hormone variants are disclosed having enhanced affinity for the growth hormone receptor. Also disclosed are human growth hormone variants conjugated to one or more chemical groups, such as poly(ethylene glycol), which is believed to prolong the  in vivo  half-life of the variants.
Patent AU-591268-B2 (AU)
Title: Method and apparatus for granulation and granulated product
Inventor: SPARKS ROBERT EDWARD
IPC: B29B9/08
Filed: 1987-03-04
Granted: 1989-11-30
Abstract: Method and apparatus for the formation of granules of a larger size or mass of a desired range from a feed stock (50) of smaller particles comprising feeding a meltable powdery material to be granulated, or a non-meltable powdery material with a meltable binder to the surface of a rotating spreader means (l0) in the form of a disk or bowl, at least a portion of which has been heated (l8) to a temperature above the melting point of the meltable compoent of the feed material wherein the rate of feeding, the energy input to the spreader means and the rotational speed of the spreader means are controlled so that there is sufficient time for at least a partial melting of the meltable component of the feed material substantially solely by contact with the heated surface of the spreader means, centrifugally spreading the material radially across the surface of the disk or bowl to form a layer of a liquid component (52) from the melted portion of the feed material on the surface of the spreader means, and dispersing the same from the edge thereof including droplets of the liquid component into an atomosphere cooler than the melting temperature to form the granulated product (54) in the cooler atmosphere. For certain materials only a part of the powdery feed material is melted forming a liquid film on the surface of the spreader means carrying a major portion of substantially unaffected or minimally affected feed material to produce a product comprising individual granules containing a core as the major part of each granule with the original powdery material essentially unchanged maintained in self-sustaining form by a matrix of melted and resolidified particles bonded to each other at their surface.
Patent AU-755632-B2 (AU)
Title: Genetically engineered duckweed
Inventor: STOMP ANNE-MARIE
IPC: A01H5/00
Filed: 1998-08-11
Granted: 2002-12-19
Abstract: Methods and compositions for the efficient transformation of duckweed arc provided. Preferably, the methods involve transformation by either ballistic bombardment or  Agrobacterium.  In this manner, any gene or nucleic acid of interest can be introduced and expressed in duckweed plants. Transformed duckweed plants, cells, tissues are also provided. Transformed duckweed plant tissue culture and methods of producing recombinant proteins and peptides from transformed duckweed plants are also disclosed.
Patent AU-556899-B2 (AU)
Title: Fibrilation of film
Inventor: ANGELLA FRANCO
IPC: B29D7/01
Filed: 1982-09-21
Granted: 1986-11-27
Abstract: Process for the netlike opening of fibrilled polymeric films, said process consisting in conveying to an opening device of the conventional type (based, for instance, on diverging transferring elements and on lateral film pulling elements such as clamps, grippers or pins, which engage the film at its edges and which are fixed on said traverse elements) the fibrilled film of an undulated or corrugated shape, with the front of the corrugations or waves perpendicular to the direction of the transferring motion, so that the length of the film between the lateral consecutive pulling elements be in excess with respect to the distance between said elements, wherefore said excess will compensate the longitudinal shrinkage that the film will suffer during the transversal opening.
Patent AU-760275-B2 (AU)
Title: Microbial genes for secreted beta-glucuronidases, gene products and uses thereof
Inventor: JEFFERSON RICHARD A
IPC: A01H5/00
Filed: 1998-09-09
Granted: 2003-05-08
Abstract: Genes encoding microbial beta-glucuronidase and protein that is secreted and its uses are provided.
Patent DE-1921591-B2 (DE)
Title: Concrete slab for road construction - has trapezoid shape with four undulating sides to increase resistance to fracture
IPC: E01C5/06
Filed: 1969-04-28
Abstract: The undulating side sections of the non-parallel sides of the slab meet the parallel sides at right angles. One parallel slab side is altogether shorter than the other side by two side sections. The sides of the slabs can be angular rather than wavy. The design is intended to increase the resistance to fracture of the road and counteract any tendency to loosening of the slabs. Pref. the shorter parallel sides have four side sections and the undulating side sections form a circular segment.
Patent DE-1966344-B2 (DE)
Title: Container transfer mechanism for shaping machine - has control valve connecting suction cup to vacuum or compressed-air sources to pick containers off mandrels and deposit them
IPC: B65B3/02
Filed: 1969-10-24
Abstract: The mechanism extracts containers from the mandrels of a spider wheel in a container shaping and transporting machine. A tappet places a suction cup against the container, the latter being deposited on a slide track. A control valve connects the suction cup either to a vacuum source or a compressed-air supply or atmosphere as desired. The valve is coupled to the tappet actuating mechanism, which in turn can be arranged to function to match the speed of the track.
Patent DE-2032052-B2 (DE)
Title: Mounting assembly fixing bell to telephone base plate - has spring hooks pressing bell assembly's support against stops
IPC: H04M1/02
Filed: 1970-06-29
Abstract: The mounting assembly, for fixing a bell to a telephone's base plate, avoids play arising from production tolerances and thereby prevents small movements in the bell and mounting assembly. The surfaces of the hooks at the ends of the springy locking arms (3) are shaped so that the arms spring forces constantly press the bell assembly's support plate (1) against stops (11). The hooks interact with springy flaps via the aforementioned surfaces.